Patient Support Programs and Home Treatment: Clinical and Organizational Requirements for Home Infusion

Reading time: 4 minuti

In recent years, Patient Support Programs (PSPs) have taken on an increasingly central role in care models, responding to the growing complexity of chronic diseases and the need to ensure the sustainability of healthcare systems. In this context, patient support programs represent a strategic tool to improve therapeutic adherence, continuity of treatment, and home-based care1,2.

Home Treatment PSPs represent one of the most advanced models in patient support services, enabling the administration of drug therapy directly at home. In particular, home infusion programs make it possible to transfer the hospital setting to the patient’s home, ensuring therapeutic continuity, clinical safety, and quality of care3.

The value of a Patient Support Program is not limited to therapy administration; it lies in the ability to design a structured organizational model capable of generating concrete benefits for patients, clinicians, the healthcare system, and pharmaceutical companies.

 

THE VALUE OF HOME TREATMENT PATIENT SUPPORT PROGRAMS FOR PATIENTS, CLINICIANS, AND PHARMACEUTICAL COMPANIES

A well-designed Home Treatment model represents a strategic tool. For patients and caregivers, home infusion reduces hospital visits and travel, with positive impacts on quality of life and daily disease management. Scientific evidence shows that PSPs improve compliance, clinical outcomes, and patient experience, while also contributing to a more efficient use of healthcare resources1,2.

For the specialist physician, this program supports clinical management and patient monitoring; for the healthcare system, it promotes greater organizational efficiency and reduces the burden on hospital care. For pharmaceutical companies, Patient Support Programs help strengthen reputation and positioning, promoting continuity of treatment and the quality of the care pathway1.

 

CRITICAL SUCCESS FACTORS OF A HOME INFUSION PATIENT SUPPORT PROGRAM

The effectiveness of a Home Treatment PSP depends on the integration of design, clinical and managerial skills, and technological infrastructure. Let’s look at the main factors that determine the program’s solidity and effectiveness.

 

NEEDS ANALYSIS AND PROGRAM DESIGN

An effective Patient Support Program stems from a structured analysis of the clinical and organizational needs of patients and clinicians. Advisory boards and focus groups gather useful information to design PSP services that align with the patient journey, focusing on therapeutic continuity and home-based care.

 

DISCIPLINARY TEAM AND PROGRAM QUALITY

The presence of a multidisciplinary team represents a key element. Alongside the Design Manager and Program Manager, who are responsible for design and operational coordination, specialist figures operate to guarantee clinical quality, regulatory compliance, and the overall value of the program.

The Medical Department defines and updates care protocols, ensuring clinical appropriateness and high quality standards, while pharmacovigilance and compliance specialists oversee the regulatory aspects required by pharmaceutical companies. In parallel, technological support helps optimize the patient experience and the overall effectiveness of the project.

 

MEDICAL DEPARTMENT AND CLINICAL SAFETY IN HOME INFUSION

The Medical Department represents a pillar of home infusion PSP programs, playing a central role in defining care protocols and training nursing staff. Operator training includes not only the technical execution of the infusion, but also the clinical management of the patient and knowledge of the disease and drug.

During service delivery, the Medical Department maintains an active role, authorizing therapy administration based on the clinical parameters detected and supporting the management of any critical issues in coordination with the specialist physician. Real-world evidence indicates that home infusion can maintain a favorable safety profile, improve therapeutic compliance, and increase patient satisfaction³,⁴.

 

TECHNOLOGY AND DIGITALIZATION OF THE PSP

Technology represents a strategic element in Patient Support Programs, as digitalization enables structured and secure clinical data collection, real-time sharing with the Medical Department and the specialist physician, and more timely patient management. In home treatment models, the technological infrastructure also allows for the monitoring of performance indicators (KPIs) and service levels (SLAs), ensuring traceability and continuous control of the program.

The integration of clinical expertise and digital tools helps improve safety, therapeutic adherence, and continuity of care, supporting the development of care models increasingly focused on home-based care and the personalization of the patient journey5.

 

CONCLUSIONS

An effective Home Treatment Patient Support Program is not limited to the administration of home therapy; it is founded on a structured organizational model capable of guaranteeing clinical quality and safety1.

In a healthcare context increasingly focused on home-based care, Patient Support Programs represent a key tool for developing home care models with high clinical and organizational value1.

 

———————————————————————————————————————

REFERENCES

  1. Sacristán JA, Artime E, Díaz-Cerezo S, Comellas M, Pérez-Carbonell L, Lizán L. The Impact of Patient Support Programs in Europe: A Systematic Literature Review. Patient. 2022 Nov;15(6):641-654.
  2. Ganguli A, Clewell J, Shillington AC. The impact of patient support programs on adherence, clinical, humanistic, and economic patient outcomes: a targeted systematic review. Patient Prefer Adherence. 2016 Apr 28;10:711-25.
  3. Toscano A, Musumeci O, Sacchini M, Ravaglia S, et al. Safety outcomes and patients’ preferences for home-based intravenous enzyme replacement therapy (ERT) in pompe disease and mucopolysaccharidosis type I (MPS I) disorder: COVID-19 and beyond. Orphanet J Rare Dis. 2023 Oct 27;18(1):338.
  4. Ceravolo F, Mascaro I, Sestito S, Pascale E, Lauricella A, Dizione E, Concolino D. Home treatment in paediatric patients with Hunter syndrome: the first Italian experience. Ital J Pediatr. 2013 Sep 9;39:53.
  5. Alotaibi YK, Federico F. The impact of health information technology on patient safety. Saudi Med J. 2017 Dec;38(12):1173-1180.